1 domain / 2 areas / 1 specialization
Route 66 Ventures
Data updated
Route 66 Ventures is a private venture capital investor that backs early-stage companies, with a stated focus on digital health and wellness as well as financial technology. Public company information places the firm in Alexandria, Virginia, United States.
In the psychedelic ecosystem, Route 66 Ventures is relevant because its portfolio includes Sensorium Therapeutics, a biotechnology company developing nature-inspired psychoactive medicines for mental health. That makes the firm a visible investor in adjacent mental health drug development rather than a generalist consumer or software fund.
Investor Context
Venture CapitalInvestment Context
This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.
Route 66 Ventures describes itself as an early-stage investor that pairs capital with operating support, and it says it focuses on companies that create better solutions to real problems, especially in digital health and wellness. Its public portfolio includes Sensorium Therapeutics, which strengthens its relevance to psychedelic-adjacent drug development and mental health innovation. The firm also states it has deployed capital since 2014 and has completed 500+ transactions, suggesting broad activity across its focus sectors.
Investor Type
Venture Capital Fund
Geographic Scope
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- HQ
- Alexandria, Virginia, United States
- Website
- Visit